📄 Direct examination of Dr. Robin Cotton (morning, part 1) — Thursday, May 11, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\11\DIRECT-EXAMINATION-OF-DR-ROBIN.DOC
TRIAL
▲ Day 72 of 167

Direct examination of Dr. Robin Cotton (morning, part 1)

Witness: Dr. Robin Cotton
Examiner: George Clarke
Called by: Prosecution • Date: Thursday, May 11, 1995 • Utterances: 321
Dr. Robin Cotton resumes direct examination, walking the jury through autoradiograph films displayed on a large light box, explaining how RFLP and PCR results are interpreted. She then systematically presents PCR typing results for multiple Bundy walkway blood drops (items 47, 48, 49, 50, 52), each time concluding that Goldman and Nicole Brown are excluded while Simpson cannot be excluded. She also addresses the shoeprint stain (item 56), which showed polymarker results consistent with Nicole Brown but inconsistent with Simpson, and the boot drop (item 78), which showed a mixture consistent with Nicole Brown and Goldman.
1 (The following proceedings were held in open court, in the presence of the jury:)
2 THE COURT:

All right. Thank you, ladies and gentlemen. Please be seated. All right. Let the record reflect that we have been rejoined by all the members of our jury panel. Good morning, ladies and gentlemen.

THE JURY: Good morning.

3 THE COURT:

All right. Dr. Cotton, would you please. Mr. Clarke, where do you anticipate questioning Dr. Cotton at this point?

4 MR. CLARKE:

I will do at the rather large light box that we have in the courtroom.

5 THE COURT:

All right.

Robin Cotton, the witness on the stand at the time of the evening adjournment, resumed the stand and testified further as follows:

6 THE COURT:

Good morning, Dr. Cotton. You are reminded you are still under oath. Mr. Clarke, you may continue.

7 MR. CLARKE:

Thank you.

8 THE COURT:

And hopefully conclude.

9 MR. CLARKE:

Yes.

10 THE COURT:

Thank you.

DIRECT EXAMINATION (RESUMED) BY Mr. CLARKE

11 MR. CLARKE:

Dr. Cotton, prior to the jury coming in, have you had an opportunity to put various of these x-ray films on this rather large light box that we have in the courtroom?

12 DR. COTTON:

Yes.

13 MR. CLARKE:

And can you describe for us first which of the films are across the top row of the light box, and there appear to be six of them?

14 THE COURT:

Excuse me, Mr. Clarke. Why don't you let counsel pass so that they can be at a vantage point.

15 (Brief pause.)
16 THE COURT:

All right. Dr. Cotton?

17 DR. COTTON:

The six films across the top are the films that have items 52, 78 and 12 along with the three known samples and the rest of the controls. The film that had the--all the dots all over it with the background isn't up here, since we didn't--weren't really able to make any interpretation from it. And the first film is the cocktail of four probes. The four films following the cocktail are each the individual films that--or the individual probes that are part of that cocktail. And the very last film is the probe that is not part of the cocktail.

18 MR. CLARKE:

Let me stop you for a moment. The top row, does it then have the film that you actually showed on the overhead projector yesterday with regard to the Bundy stain?

19 DR. COTTON:

Yes.

20 MR. CLARKE:

Rockingham foyer stain?

21 DR. COTTON:

Yes.

22 MR. CLARKE:

And the boot stain?

23 DR. COTTON:

Yes, with the exception of the one that has background on it.

24 MR. CLARKE:

Now, on the lower row there appears to be one more film. What is it?

25 DR. COTTON:

That is the film that was also passed out to the jury that has item 56 and the three known individuals.

26 MR. CLARKE:

All right. Then with the Court's permission I'm going to light the light box and then ask the jurors further questions--I'm sorry, ask the witness further questions.

27 (Brief pause.)
28 THE COURT:

All right. Proceed.

29 MR. CLARKE:

Thank you.

30 MR. CLARKE:

Now, Dr. Cotton, now that you have an opportunity to have all of these x-ray films on the light box at one time, would the fact that they are all together be helpful in explaining anything that yesterday you weren't able to explain as well because these films were not done all at one time or shown at one time?

31 DR. COTTON:

There are two things that are useful in terms of putting them up on the light box. One is to just illustrate to you how they can be superimposed one on the other to identify the band in the cocktail. And then also this is a much more optimal way to view them, not from quite that far away, but in terms of seeing bands, that are not very dark.

32 MR. CLARKE:

All right. With respect to the upper row then, can you point out for us what you are talking about and which of these films show, for instance, this lightness and darkness and so forth that it would be helpful to see while they are up all at one time?

33 DR. COTTON:

The only pattern that we need to pay attention to, in terms of where do we have light bands, is the item 52 pattern, and the bands are most clearly visible on the cocktail, but individually one can go through and pick out bands. The other bands in the sample are pretty much easy to see, perhaps with one or two exceptions on item 52. MS1 has a single band. It is up here where my finger is pointing, (Indicating), for item 52. For MS31 the bands are quite easy to see. For MS43 again they are very light and two of them for g3, they look fairly clear, but still light, and for YNH24 they are clear but still light. So that is what you would be looking at if you were in the laboratory. You would be viewing it on a light box like there on your desk or on the counter or something.

34 MR. CLARKE:

And again, when you are referring to 52, you are referring to the stain from the Bundy walkway?

35 DR. COTTON:

That's right.

36 MR. CLARKE:

Now, there is one more autoradiograph x-ray that is down below and I believe you said that is the particular film that was used in an attempt to type the shoeprint, no. 56?

37 DR. COTTON:

That's right.

38 MR. CLARKE:

And that yielded or produced no results, correct?

39 DR. COTTON:

That's right.

40 MR. CLARKE:

Does that give you then the opportunity to show what a lane looks like that has no DNA in it versus lanes that have more DNA and then lanes with more DNA still when you compare all seven of these films?

41 DR. COTTON:

Well, when you say it has no DNA in it, that is not literally loaded. It just isn't human so there is no human DNA there and it just is an example of the lane that has absolutely no bands in it at all.

42 MR. CLARKE:

All right. While these six films--I'm sorry, seven films are present on the light box, is there anything further that you feel would be appropriate to point out in this comparison process?

43 DR. COTTON:

Just in terms of understanding how these films relate to one another, let me pull one down and give an illustration, which won't be enormously easy to see, but hopefully you will get the idea. Let's use as an example, because it is fairly easy to see, let's look at item no. 12. If we wanted to identify in item no. 12 which of the bands here was produced by which probe, one can--and here is the band I'm going to follow for MS1. Because these all came from the same membrane, they are superimposable, you can lay these one on top of the other, and I've just now moved the top one slightly to the right and I can see that the top band for item no. 12 is the band that is produced by MS1 and they are--can be superimposed well enough so that now you can't really see that you have two films there.

44 MR. CLARKE:

Just for the record, Dr. Cotton, have you just taken the film that is labeled 257-b and placed it over the film labeled 257-a?

45 DR. COTTON:

Yes. And then you would go on and continue that process, and I went go through all six films, but if you go on to the next film, MS31, you can do exactly the same thing, and I can determine from that that the two bands that are in the middle here, the bottom two of this group of three, are the band in the cocktail that are produced by MS31. So once all the films have been completed, that is the procedure that you can use in the laboratory to go through and say, well, if I'm going to take my sizes from this film, which is the easiest thing to do, then I can identify which probes each of those bands comes from by simply superimposing them, making that identification and then noting that in your case materials.

46 MR. CLARKE:

All right. Dr. Cotton, while we have these films on the board, I would like you to assume, and let's start with no. 56, the shoeprint from the Bundy scene, I would like you to assume that with regard to that particular bloodstain, that that was from a bloodstain and that was found on a walkway outside in an area that has leaves and apparent soil nearby.

47 MR. NEUFELD:

Objection, assumes a fact not in evidence.

48 THE COURT:

Overruled.

49 MR. CLARKE:

And that that item was collected during a late morning time period on a given day. I would then like to shift your attention to item no. 52 from the Bundy walkway, and that would be referring you to the films that are exhibit 257-A, B, C and so forth, and I would like you to assume that that was found on a concrete type driveway in an apparent cleaner area than item 56, but collected at approximately the same time that day, same day. And then lastly, I would like you to assume, with regard to item no. 12, that that in fact was blood staining from an indoor area, that is, inside a home on a floor and that that was collected later the same day in the late afternoon, approximately. With those assumptions, do these results that you've obtained, are they consistent with degradation of DNA in relative amounts?

50 DR. COTTON:

With the assumptions that you've just given me, the state of the DNA, the amount of degradation that we see in these three samples that you mentioned, is consistent with the types of environment that you have just described.

51 MR. CLARKE:

Why? Can you explain that?

52 DR. COTTON:

There have been a number of experiments published and also based on our own experience and talking with people from other DNA laboratories, we know that if a sample is exposed to soil or leaves, the likelihood of getting DNA from that sample that is good enough to use for RFLP is very low.

53 MR. CLARKE:

All right. How does the comparison of these three items, how does that play a role in your conclusions?

54 DR. COTTON:

If item 56 was in an area where there were leaves or dirt or soil, the fact that we did not get any human DNA, but we did get DNA that was possibly bacterial DNA, is consistent with the assumption that you asked me to make.

55 MR. CLARKE:

All right. What about then the relative conditions of the DNA with regard then to the Bundy stain, 52, and the Rockingham foyer stain, no. 12?

56 DR. COTTON:

The Bundy stain 52 has less DNA and DNA which is more degraded than the DNA in item no. 12,. And if item no. 12 was collected from a cleaner location than item no. 52, that would be consistent with the condition of the DNA as it is seen on the autorads and as it was seen on the small gel that was done after the DNA extraction.

57 MR. CLARKE:

Incidentally, when, for instance, a human cuts himself or herself and begins to bleed, does one's blood, as it is coming from one's body, have bacteria in it?

58 DR. COTTON:

Not unless one is very ill.

59 MR. CLARKE:

So the bacteria comes from where then?

60 DR. COTTON:

The bacteria in the blood would be then coming from whatever the blood was deposited on.

KEY QUOTE
61 MR. CLARKE:

All right. At this time, your Honor, it would be my request that the jurors have an opportunity to walk by and examine these particular films while they are on the light box.

62 THE COURT:

All right. Let's have the jurors in row no. 1 then, starting with juror no. 1, if could you file by the light box and then re-enter the jury box at the other jury door, please, and take your time.

63 (The jurors view the autorads.)
64 THE COURT:

Mr. Clarke.

65 MR. CLARKE:

Yes, thank you. Now, Dr. Cotton, if I could ask you to remove the films that are on the light box right now, which are People's exhibits 257, I believe a through--

66 THE COURT:

The complete series of 257.

67 MR. CLARKE:

The complete series except for 257-c.

68 THE COURT:

All right.

69 MR. CLARKE:

As well as exhibit 246.

70 MR. CLARKE:

And I'm going to ask if you would now place on the board the films that constitute People's exhibits 258-a through f regarding the sock.

71 (Brief pause.)
72 MR. CLARKE:

Now, Dr. Cotton, with regard to People's exhibit 258, those six films, first of recall, with regard to the sock, are there any faint or weak bands that you need to point out?

73 DR. COTTON:

No, there aren't.

74 MR. CLARKE:

All right. Your Honor, again with the permission of the Court may the jury view this set of autoradiographs?

75 THE COURT:

Yes.

76 (The jury views the autorads.)
77 MR. NEUFELD:

Your Honor, while they are looking at that, may we approach for one second?

78 THE COURT:

Sure.

79 MR. NEUFELD:

Okay.

80 (A conference was held at the bench, not reported.)
81 (The following proceedings were held in open court:)
82 THE COURT:

The record should reflect that each of the jurors has had and taken the opportunity to view both series of autorads.

83 MR. CLARKE:

Your Honor. May we remove the large light box?

84 THE COURT:

Yes.

85 (Brief pause.)
86 THE COURT:

Mr. Clarke.

87 MR. CLARKE:

Thank you, your Honor.

88 MR. CLARKE:

Dr. Cotton, in the course of your testing, you described earlier the fact that you tested a number of samples that you received using the PCR process?

89 DR. COTTON:

That's right.

90 MR. CLARKE:

How did you decide whether--well, let me rephrase. How did you decide whether to type a sample using PCR or RFLP or both?

91 DR. COTTON:

If the DNA was in sufficiently good condition for both, we did both. If it wasn't in sufficiently good condition to do RFLP, we then did PCR.

92 MR. CLARKE:

With regard to the samples that you identified on those boards that had a number of different photographs of envelopes and so forth, did you in fact test those samples either by RFLP or PCR or both?

93 DR. COTTON:

Yes.

94 MR. CLARKE:

And did you obtain results from a number of those samples?

95 DR. COTTON:

Yes, we did.

96 MR. CLARKE:

Your Honor, at this time I would ask to be marked as People's next in order what I believe could be described as the Bundy results board.

97 THE COURT:

All right. 259.

98 (Peo's 259 for id = posterboard)
99 MR. CLARKE:

And I'm going to also ask the Court's permission to be able to place in the location under the projector screen with a second tripod the earlier board, exhibit 165, that is the photo board for the Bundy crime scene.

100 THE COURT:

Refresh my recollection as to 165. Do we have victims depicted?

101 MS. CLARK:

I don't think so. I don't think so.

102 MR. CLARKE:

No, your Honor.

103 THE COURT:

All right.

104 (Brief pause.)
105 THE COURT:

All right. Where is Mr. Neufeld?

106 THE COURT:

I was just making sure you were positioning yourself so you could see.

107 MR. CLARKE:

Your Honor, incidentally, the Defense have copies of these boards they were given with the material shown on them.

108 THE COURT:

All right.

109 (Brief pause.)
110 MR. SCHECK:

Your Honor, could we approach just on arrangements?

111 THE COURT:

On the arrangements?

112 MR. SCHECK:

In other words, with the new configuration of the courtroom, I have a suggestion about the boards. Oh, I see, it is that one. It is impossible.

113 THE COURT:

And we may have to move it back to give Dr. Cotton some ingress-egress there.

114 (Brief pause.)
115 THE COURT:

All right. Let's proceed.

116 THE BAILIFF:

Excuse me, your Honor. You have a couple jurors that can't see.

117 THE COURT:

All right. Mr. Clarke, the difficulty is the height of the Bundy board, 165.

118 MR. CLARKE:

All right. Then perhaps as I refer to individual items we can raise it or point out as necessary.

119 THE COURT:

All right.

120 MR. CLARKE:

All right. Dr. Cotton, with respect to various items of evidence, and if I may, I will direct you to specific item numbers and a brief description of them, do you have before you the results that your laboratory obtained, whether it is PCR results or RFLP results?

121 DR. COTTON:

Yes, I do.

122 MR. CLARKE:

All right. Initially were you asked and did you test an item no. 47 described as "first drop by the victims at Bundy"?

123 DR. COTTON:

Yes, we did.

124 MR. CLARKE:

What type of testing did you use with respect to that item?

125 DR. COTTON:

PCR testing.

126 MR. CLARKE:

At how many markers, and we will try to do this as to this first marker and perhaps shorten it with the remaining markers?

127 DR. COTTON:

Six.

128 MR. CLARKE:

And would one of those markers be DQ-Alpha?

129 DR. COTTON:

Yes.

130 MR. CLARKE:

And the other five markers would be what?

131 DR. COTTON:

They are the five markers that compile the polymarker.

132 MR. CLARKE:

And did you obtain results from that testing?

133 DR. COTTON:

Yes, we did.

134 MR. CLARKE:

All right. With respect to those results can you describe what the DQ-Alpha result was?

135 DR. COTTON:

The DQ-Alpha result was a 1.1, 1.2.

136 MR. CLARKE:

Now, I'm going to ask you and perhaps--have you had a chance to look at these results boards before, Dr. Cotton?

137 DR. COTTON:

Yes, I have.

138 MR. CLARKE:

And have you had an opportunity to look at not only the various items of evidence that are listed on the board, but also the known types of the three people in this case, Mr. Simpson, Nicole Brown and Ronald Goldman, that are listed at the very top of the diagram?

139 DR. COTTON:

Yes, I have.

140 MR. CLARKE:

With regard to the known types, that is the DQ-Alpha types, are the types shown on this board, People's exhibit 259, with respect to those three known persons, accurate?

141 DR. COTTON:

Yes, they were.

142 MR. CLARKE:

Now, with regard to again item no. 47, this first drop by the victims at Bundy, did you also obtain polymarker results at those five additional markers?

143 DR. COTTON:

Yes, we did.

144 MR. CLARKE:

As a result of those tests, that is the results you obtained, were you able to include or exclude any of the three parties as far as being contributors of that sample, possible contributors?

145 DR. COTTON:

Yes, we were.

146 MR. CLARKE:

All right. Could you tell us who was excluded, if anyone, and who was included?

147 DR. COTTON:

Nicole Brown and Ronald Goldman are excluded and Mr. Simpson is a possible contributor.

KEY QUOTE
148 MR. CLARKE:

All right. With the Court's permission I'm going to remove the current cover that shows those results as far as this particular item.

149 THE COURT:

Yes. All right. Mr. Fairtlough, could we raise this board up?

150 MR. FAIRTLOUGH:

Yes, your Honor.

151 MS. CLARK:

Your Honor, can we approach, please? We have a logistical problem here.

152 THE COURT:

Well, if it is a logistical problem, I can assume you can settle it yourselves. Proceed.

153 (Brief pause.)
154 THE COURT:

Proceed.

155 MR. CLARKE:

Thank you.

156 MR. CLARKE:

Let me see if I can get on my tip toes. I don't know if you can see, Dr. Cotton, but have I --

157 DR. COTTON:

I can't see it.

158 MR. CLARKE:

Okay. With regard to what is beneath that cover that I just removed, and this is item no. 47, your laboratory, it states "DQ-Alpha 1.1, 1.2" and then it says "polymarker included"?

159 DR. COTTON:

That would be correct.

160 MR. CLARKE:

You previously or just a few moments ago testified that these results, including all six of these genetic markers, exclude Mr. Goldman and Nicole Brown; is that right?

161 DR. COTTON:

That's right.

162 MR. CLARKE:

And is Mr. Simpson then included as a possible donor of that blood stain?

163 DR. COTTON:

Yes, he is.

164 (Discussion held off the record between the Deputy District Attorneys.)
165 MR. CLARKE:

When you use the term "included," again does that mean he is or is not a possible source of that DNA?

166 DR. COTTON:

When you say that he is included, it means that he is a possible source.

167 MR. CLARKE:

Now, turning your attention to the next item on the board, which is labeled "no. 48 Bundy walk," did you also test that sample using PCR?

168 DR. COTTON:

I think I have to go to a different report, so you need to give me a second.

169 MR. CLARKE:

All right.

170 (Brief pause.)
171 MR. CLARKE:

Your Honor, while the witness is looking, I'm also going to remove the second magnetic portion of the board that is under the column "not excluded" relating to item no. 47, the first drop.

172 THE COURT:

Proceed.

173 MR. CLARKE:

It is a good thing these are getting lower, too, as we go.

174 (Brief pause.)
175 DR. COTTON:

Yes, we did have that sample.

176 MR. CLARKE:

And did you test that sample for the same six genetic markers using PCR?

177 DR. COTTON:

Yes, we did.

178 MR. CLARKE:

With what result?

179 DR. COTTON:

Did you want me to read the type or just--

180 MR. CLARKE:

Actually, were your results the same or different than 47, the first drop by the victims?

181 DR. COTTON:

They were the same.

182 MR. CLARKE:

Does that mean then that the types were DQ-Alpha 1.1, 1.2 and as to the polymarker an individual was included?

183 DR. COTTON:

That's right.

184 MR. CLARKE:

Do those results include or exclude Mr. Goldman and Nicole Brown?

185 DR. COTTON:

They exclude Mr. Goldman and Nicole Brown.

186 MR. CLARKE:

What about Mr. Simpson?

187 DR. COTTON:

They do not exclude him.

188 MR. CLARKE:

Your Honor, your Honor, with the Court's permission, I'm going to remove again both magnetic markers as to item 48, the Bundy walkway.

189 THE COURT:

You may.

190 MR. CLARKE:

Drawing your attention, Dr. Cotton, to no. 49, another Bundy walkway stain, did you type that particular evidence using these same six genetic markers using PCR?

191 DR. COTTON:

Yes, we did.

192 MR. CLARKE:

With what results?

193 DR. COTTON:

Mr. Simpson is included as a possible donor and Nicole Brown and Ronald Goldman are excluded as possible donors.

194 MR. CLARKE:

Now, does that include or were your results as to no. 49 on the Bundy walkway the same as for the first two items, 47 and 48, the other Bundy walkway stains?

195 DR. COTTON:

Yes, they are.

196 MR. CLARKE:

Your Honor, again with the Court's permission I'm going to reveal the two appropriate covers.

197 THE COURT:

Yes.

198 (Brief pause.)
199 THE COURT:

Miss Martinez, is it possible we could move the cart there just slightly?

200 (Brief pause.)
201 THE COURT:

Thank you.

202 MR. CLARKE:

Now, referring you to what's marked no. 50, bloodstains from the Bundy walkway, did you also test that sample?

203 DR. COTTON:

Yes, we did.

204 MR. CLARKE:

Did you use the same or different genetic markers using PCR typing?

205 DR. COTTON:

The same.

206 MR. CLARKE:

And with regard to the results, can you tell us what they were?

207 DR. COTTON:

With regard to item no. 50, Nicole Brown and Ronald Goldman are excluded and Mr. Simpson is included as a possible donor.

208 MR. CLARKE:

All right. Your Honor, with regard again to those results, I'm going to, with the Court's permission, reveal the appropriate markers.

209 THE COURT:

Proceed.

210 (Brief pause.)
211 MR. CLARKE:

Turning your attention now to no. 52, which is labeled "the Bundy walkway," first of all, you have already described RFLP results with respect to that Bundy stain; is that right?

212 DR. COTTON:

That's right.

213 MR. CLARKE:

And I believe you described that there was a match between Mr. Simpson and this stain at a number of genetic markers; is that right?

214 DR. COTTON:

That's correct.

215 MR. CLARKE:

Or probes as you have used the term?

216 DR. COTTON:

That's right.

217 MR. CLARKE:

How many probes did Mr. Simpson match the 52 Bundy stain at?

218 DR. COTTON:

Five.

219 MR. CLARKE:

Your Honor, with the Court's permission, there is a column with "RFLP results" and I'm going to ask to be able to reveal that at this time also.

220 THE COURT:

Proceed.

221 (Brief pause.)
222 MR. CLARKE:

In other words, Dr. Cotton, was there a five-probe match between Mr. Simpson and no. 52, the Bundy stain, using your RFLP technique?

223 DR. COTTON:

Yes, there was.

224 MR. CLARKE:

Did you also test that sample using PCR?

225 DR. COTTON:

Yes, we did.

226 MR. CLARKE:

With what results?

227 DR. COTTON:

You will have to wait just a second because I thought I had turned to the correct page and I haven't.

228 (Brief pause.)
229 (Discussion held off the record between the Deputy District Attorneys.)
230 DR. COTTON:

Oh, yes, I have. Okay.

231 MR. CLARKE:

First of all, was that the same stain, and I'm referring to item no. 52, that you discussed as far as RFLP results yesterday?

232 DR. COTTON:

Yes, the same stain.

233 MR. CLARKE:

With what results as far as PCR is concerned?

234 DR. COTTON:

The PCR results exclude Mr. Goldman and Nicole Brown and they include Mr. Simpson.

235 MR. CLARKE:

All right. Again, your Honor, with the Court's permission, I would like to reveal the remaining two magnetic covers.

236 THE COURT:

Yes.

237 (Brief pause.)
238 MR. CLARKE:

Now, I would like to turn your attention to the shoeprint, item no. 56, which you've testified I'm sorry--testified about already both yesterday and today as far as RFLP typing.

239 DR. COTTON:

Yes.

240 MR. CLARKE:

And you obtained no RFLP results as to that shoeprint stain; is that right?

241 DR. COTTON:

That's correct.

242 MR. CLARKE:

What about PCR? Did you obtain any results as to that item?

243 DR. COTTON:

Yes, we did.

244 MR. CLARKE:

What were they?

245 DR. COTTON:

We obtained polymarker results and we did get some signal on the DQ-Alpha results, but there was no C dot.

246 MR. CLARKE:

When you say no C dot, that is one of the controls you described?

247 DR. COTTON:

That is one of the controls, and because we didn't see a C dot, we noted the types that we could see, but that doesn't mean that there aren't other types that we couldn't see.

248 MR. CLARKE:

Was there anything about the--well, what types did you see as far as DQ-Alpha was concerned?

249 MR. NEUFELD:

Objection, your Honor. May we approach?

250 THE COURT:

Sustained. I'm going to sustain the objection.

251 MR. CLARKE:

Was there anything about the results using DQ-Alpha that excluded Mr. Simpson?

252 DR. COTTON:

Using DQ-Alpha alone, given that we didn't see a C dot, we can't exclude him.

253 MR. CLARKE:

What about the polymarker results?

254 DR. COTTON:

The polymarker results had a--the control turned out okay and, umm, those results are--hang on one second.

255 (Brief pause.)
256 DR. COTTON:

Those results are not consistent with Mr. Simpson.

KEY QUOTE
257 MR. CLARKE:

With regard to the other two parties in this case, were those results consistent or inconsistent with them?

258 DR. COTTON:

They are consistent with Nicole Brown and inconsistent with Ronald Goldman.

259 MR. CLARKE:

Let me stop you just for a moment or go back, if I can. When you said there was no C dot on this DQ-Alpha marker, what does that mean?

260 DR. COTTON:

The C dot is designed to say that you have enough amplified product to reliably interpret your results. If the--if you have no C dot, then what that means is that you may have so little amplified product that you could have a person, for example, that had two alleles but you might only see one of them, so your typing would--the type that you see is one of the types that is there, but it may not be all of the types that are there.

261 MR. CLARKE:

Is that one of the built-in controls in the test that you described--

262 DR. COTTON:

Yes, it is.

263 MR. CLARKE:

--previously. With regard to this result from the shoeprint then, and I'm referring then to the polymarker results, was a particular individual included?

264 DR. COTTON:

Yes.

265 MR. CLARKE:

Who was that?

266 DR. COTTON:

Nicole Brown.

267 MR. CLARKE:

All right. Your Honor, with regard to the shoeprint, I would ask the Court for permission to remove those covers.

268 THE COURT:

Yes.

269 (Brief pause.)
270 MR. NEUFELD:

One second, your Honor.

271 (Brief pause.)
272 MR. NEUFELD:

Your Honor, I have an objection. May we approach?

273 THE COURT:

No. It has already been taken care of. The objection is overruled.

274 MR. CLARKE:

Turning your attention, Dr. Cotton, to item no. 78, the Ronald Goldman boot drop, you have already described RFLP results over the last couple days, correct?

275 DR. COTTON:

That's right.

276 MR. CLARKE:

How many probes were actually used in this test of that boot drop?

277 DR. COTTON:

Five.

278 MR. CLARKE:

And that is the RFLP probes?

279 DR. COTTON:

Yes.

280 MR. CLARKE:

All right. Your Honor, with the Court's permission I'm going to ask to remove the cover as far as RFLP testing is concerned.

281 THE COURT:

Yes.

282 (Brief pause.)
283 MR. CLARKE:

Did you also conduct PCR testing with regard to no. 78, the boot drop?

284 DR. COTTON:

Yes, we did.

285 MR. CLARKE:

And did you test that at these six genetic markers, including DQ-Alpha?

286 DR. COTTON:

Yes, we did.

287 MR. CLARKE:

With what results?

288 DR. COTTON:

The results indicate that there are a mixture of two people in the sample.

KEY QUOTE
289 MR. CLARKE:

Far as those results, can you include or exclude any of the three persons; Mr. Simpson, Nicole Brown or Ronald Goldman?

290 DR. COTTON:

Mr. Simpson is excluded and Nicole Brown and Ronald Goldman cannot be excluded.

291 MR. CLARKE:

All right. Your Honor, with this item I would ask for permission to remove the two magnetic covers.

292 THE COURT:

Yes.

293 (Brief pause.)
294 THE COURT:

Excuse me. Mr. Fairtlough, before you bring up something that has got a victim's body in it, would you warn me, please.

295 MS. CLARK:

Your Honor, could you cut the feed for this?

296 THE COURT:

I have, but--

297 MR. CLARKE:

Now, as far as the polymarker results well, let me step--go one step backwards. The DQ-Alpha results on the boot drop, they show what appear to be three types, plus the possibility of a fourth?

298 DR. COTTON:

That's right.

299 MR. CLARKE:

Is that what leads you to the conclusion that that is a mixture?

300 DR. COTTON:

That's right.

301 MR. CLARKE:

Did the polymarker results also show a mixture?

302 DR. COTTON:

The polymarker results don't have any locus that has three types in it, so it is not clear from the polymarker results alone that there is a mixture, and the differences in the intensities of the blue dots are not really quite good enough to indicate definitely that there is or is not, so the determination that there is a mixture relies on the DQ-Alpha results.

303 MR. CLARKE:

Now, as far as those DQ-Alpha results, there are three types listed, 1.1, 1.3 and 4. Did you obtain those types?

304 DR. COTTON:

Yes, we did.

305 MR. CLARKE:

And then you also note, do you not, "possible 1.2"?

306 DR. COTTON:

That's right.

307 MR. CLARKE:

Why is it a possible 1.2?

308 DR. COTTON:

When you have more than one individual in the DQ-Alpha test, the way the strips are designed is that you wouldn't be able to definitively read the 1.2 if you have a certain combination of alleles, and you have more than one person. If you only have a single person, there is no problem, so when there is clearly a mixture, which there is here, and you can't definitively say whether the 1.2 is there or not, then it is generally reported as you have the alleles that you can define and you have a possible 1.2 and you can't say that it is or is not definitively there.

309 MR. CLARKE:

Now, turning your attention to what are listed as items no. 84-a and 84-b, the left and right-hand fingernail clippings and scrapings of Nicole Brown, did you type those items using PCR?

310 DR. COTTON:

Yes, we did, but you will have to give me a second to locate the report.

311 MR. CLARKE:

All right. If you would.

312 (Brief pause.)
313 MR. NEUFELD:

Your Honor, I would object to foundation on those fingernail scrapings that come--I don't think they were sent directly from--

314 MS. CLARK:

Speaking objection.

315 MR. CLARKE:

Excuse me, your Honor.

316 THE COURT:

Mr. Clarke.

317 MR. CLARKE:

I believe that was a speaking objection.

318 THE COURT:

It was.

319 MR. NEUFELD:

May we approach, your Honor?

320 THE COURT:

Yes. With the court reporter, please.

321 MR. NEUFELD:

Thank you.

Temperature

procedural

Key Quotes (5)

Dr. Robin Cotton
Nicole Brown and Ronald Goldman are excluded and Mr. Simpson is a possible contributor.
Repeated conclusion for items 47, 48, 49, 50, and 52 — the Bundy walkway drops — systematically placing Simpson's DNA at the crime scene
Dr. Robin Cotton
Yes, there was.
Confirming a five-probe RFLP match between Simpson and item 52, the Bundy walkway stain — the strongest DNA match presented
Dr. Robin Cotton
Those results are not consistent with Mr. Simpson.
Polymarker results from the shoeprint (item 56) exclude Simpson — a notable exception in an otherwise damning presentation, consistent with the shoeprint being Nicole Brown's blood
Dr. Robin Cotton
The bacteria in the blood would be then coming from whatever the blood was deposited on.
Explains why item 56 (shoeprint near soil and leaves) yielded no human DNA — degradation from environmental contamination, not evidence tampering
Dr. Robin Cotton
The results indicate that there are a mixture of two people in the sample.
Boot drop (item 78) shows a mixture consistent with Nicole Brown and Goldman — placing both victims' blood together

Evidence (11)

People's 257-a through f (excluding 257-c)
RFLP autoradiograph films for items 52 (Bundy walkway), 78 (boot drop), 12 (Rockingham foyer), plus known samples and controls
displayed on light box, viewed by jury, superimposition technique demonstrated
People's 246
Additional autoradiograph for item 56 (shoeprint), showing no human DNA bands
removed from light box after jury viewing
People's 258-a through f
Six RFLP autoradiograph films for the sock evidence
placed on light box and viewed by jury
People's 259
Bundy results posterboard summarizing PCR and RFLP results for all Bundy evidence items with known types for Simpson, Nicole Brown, and Goldman at top
introduced, magnetic covers progressively removed as results confirmed
People's 165
Bundy crime scene photo board
placed alongside results board for reference; partially obscured juror sightlines, requiring repositioning
Informal
Item 47 — first drop by victims at Bundy walkway
PCR results presented: DQ-Alpha 1.1, 1.2; polymarker included Simpson, excluded Nicole Brown and Goldman
+ 5 more

Notable Exchanges (3)

George ClarkeDr. Robin Cotton
Clarke's hypothetical about degradation — asking Cotton to assume item 56 was near soil/leaves, item 52 on cleaner concrete, and item 12 was indoors — and whether the relative DNA quality was consistent with those environments. Cotton confirmed it was, providing scientific cover for the prosecution's narrative about why the shoeprint yielded no results.
strategic
Dr. Robin Cottonjury
Jurors filed past the light box in two separate sessions to view the autoradiograph films up close — first the 257 series (Bundy/Rockingham/boot), then the 258 series (sock). A bench conference occurred during the second viewing.
procedural
Peter NeufeldLance A. Ito
Neufeld attempted a speaking objection on foundation for the fingernail scrapings, was called out by both Clarke and the judge, then requested a bench conference which was granted.
strategic

Light Moments (3)

Lance A. Ito
Ito's dry aside to Clarke when resuming examination: 'And hopefully conclude.'
George Clarke
Clarke on the progressively lower magnetic covers on the results board: 'It is a good thing these are getting lower, too, as we go.'
George Clarke
Clarke struggling with board visibility: 'Let me see if I can get on my tip toes.'

Witness Demeanor

Methodical and technically precise throughout; paused multiple times to locate correct report pages
Demonstrated superimposition technique physically with autoradiograph films
No stage directions indicating emotional response

Objections

3 objections (1 sustained, 1 overruled)
Proceeding 6017 • 321 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 11, 1995 📄 Direct examination of Dr. Robi
MAY 11, 1995 KRT DvH TD